Skip to main content

Institutional intelligence for Marksans Pharma Ltd

Cross-view mutual fund activity and super-investor shareholding · Jun 2026 SHP.

Ownership breakdown

Category totals from the official quarterly Shareholding Pattern filing (Jun 2026). Sums to 100.00%.

  • Promoters43.87%
  • FII17.47%
  • Mutual Funds4.36%
  • DII (ex-MF)1.83%
  • Retail & others32.47%
  • 1% Club 1.14%(subset)

Super Investors and 1% Club names below are disclosed holders at or above 1%. They are subsets of the categories above, not additive. View filing

Holder details (≥1% disclosed names)

Promoters

Promoter & promoter group

43.87%1 named
HolderStakeSharesValue (₹ Cr)
43.80%19,84,91,553₹5.34k Cr

Retail & others

Holders below 1% disclosure threshold and public non-institutions

32.47%

SEBI requires naming only shareholders with ≥1% stake. The remaining 32.47% includes retail investors, small HNIs, employee trusts, and other holders below the disclosure threshold — aggregated in the official filing.

FII / FPI

Foreign portfolio investors

17.47%1 named
HolderStakeSharesValue (₹ Cr)
8.62%3,90,50,881₹1.05k Cr

Mutual Funds

Domestic mutual funds & UTI

4.36%1 named
HolderStakeSharesValue (₹ Cr)
2.11%95,61,028₹257.1 Cr

1% Club — Individuals & others

Non-promoter ≥1% holders not matched to a curated profile

1.14%1 named
HolderStakeSharesValue (₹ Cr)
1.14%51,47,937₹138.4 Cr

DII (other)

Insurance, banks, AIF, other domestic institutions

1.83%No names

No named holders ≥1% in this bucket.

Super Investors

Curated tracked investor profiles

No names

No curated super investor holds ≥1% in the latest filing. See FII, DII, and mutual fund holders in the sections above.

Shareholding data sourced from NSE/BSE regulatory filings. Category chart uses official filing totals; named holder lists include every disclosed ≥1% position. Not investment advice. See our disclaimer and methodology.